RoboticsConfidence BUnited Statesactive

Valink Therapeutics

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Official websitevalinktx.com
RegionBoston, United States
CategoryRobotics / Embodied AI
Funding statusUnknown · Undisclosed
Last updatedJun 11, 2026
Latest signalJun 11, 2026

Status timeline

Funding, product, customer, team, and correction signals
Jun 10, 2026Confidence A
Product0 evidence links

Valink Therapeutics product scope reviewed

Valink Therapeutics public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.
Jun 10, 2026Confidence B
Funding0 evidence links

Valink Therapeutics capital or status signal reviewed

Valink Therapeutics public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
Jun 10, 2026

Unknown

AmountUndisclosed
InvestorsY Combinator profile
EvidenceConfidence B
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels

Valink Therapeutics official product profile

Valink Therapeutics official site · official
Confidence A

Valink Therapeutics official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

Valink Therapeutics capital or status signal

Y Combinator Startup Directory · registry
Confidence B

Valink Therapeutics public capital or strategic-status source reviewed for stage and timeline signal.

Trust BPublic review
Open source

Similar projects

Same category or overlapping tags